CN101759574A - 3-甲胺基-1,2-丙二醇的合成方法 - Google Patents
3-甲胺基-1,2-丙二醇的合成方法 Download PDFInfo
- Publication number
- CN101759574A CN101759574A CN200910256073A CN200910256073A CN101759574A CN 101759574 A CN101759574 A CN 101759574A CN 200910256073 A CN200910256073 A CN 200910256073A CN 200910256073 A CN200910256073 A CN 200910256073A CN 101759574 A CN101759574 A CN 101759574A
- Authority
- CN
- China
- Prior art keywords
- methylamino
- distillation
- monomethylamine
- amination
- propylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract description 23
- WOMTYMDHLQTCHY-UHFFFAOYSA-N 3-methylamino-1,2-propanediol Chemical compound CNCC(O)CO WOMTYMDHLQTCHY-UHFFFAOYSA-N 0.000 title abstract description 7
- 230000002194 synthesizing effect Effects 0.000 title abstract 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims abstract description 82
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 57
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 44
- 238000005576 amination reaction Methods 0.000 claims abstract description 40
- 238000004821 distillation Methods 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims abstract description 30
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 claims abstract description 22
- 235000011187 glycerol Nutrition 0.000 claims abstract description 22
- 238000006243 chemical reaction Methods 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000000243 solution Substances 0.000 claims abstract description 17
- 239000007864 aqueous solution Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- 239000000047 product Substances 0.000 claims description 26
- 239000003039 volatile agent Substances 0.000 claims description 17
- 238000010189 synthetic method Methods 0.000 claims description 12
- 239000010409 thin film Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 4
- 238000006555 catalytic reaction Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 239000010408 film Substances 0.000 claims description 3
- 239000011344 liquid material Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 abstract description 16
- 229960002603 iopromide Drugs 0.000 abstract description 16
- 239000002872 contrast media Substances 0.000 abstract description 13
- 238000001914 filtration Methods 0.000 abstract description 5
- 230000008676 import Effects 0.000 abstract description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 239000012265 solid product Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 16
- 239000012071 phase Substances 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 230000004044 response Effects 0.000 description 7
- 239000011343 solid material Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000005265 energy consumption Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 description 2
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 2
- 206010020852 Hypertonia Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000009481 Laryngeal Edema Diseases 0.000 description 1
- 206010023845 Laryngeal oedema Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- -1 hydroxyl groups compound Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 208000003663 ventricular fibrillation Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
序号 | 检测指标 | 分析方法 | 检测结果 |
1 | 外观 | 目测 | 无色透明液体 |
2 | 纯度(GC)(%) | 企业标准Q/WZY011-2009 | 99.56 |
3 | 主峰前馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.12 |
4 | 主峰后馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.32 |
5 | 水分含量(wt%) | 卡尔·费休法 | 0.93 |
序号 | 检测指标 | 分析方法 | 检测结果 |
1 | 外观 | 目测 | 无色透明液体 |
2 | 纯度(GC)(%) | 企业标准Q/WZY011-2009 | 99.61 |
3 | 主峰前馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.14 |
4 | 主峰后馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.25 |
5 | 水分含量(wt%) | 卡尔·费休法 | 1.07 |
序号 | 检测指标 | 分析方法 | 检测结果 |
1 | 外观 | 目测 | 无色透明液体 |
2 | 纯度(GC)(%) | 企业标准Q/WZY011-2009 | 99.65 |
序号 | 检测指标 | 分析方法 | 检测结果 |
3 | 主峰前馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.09 |
4 | 主峰后馏分含量(GC)(%) | 企业标准Q/WZY011-2009 | 0.26 |
5 | 水分含量(wt%) | 卡尔·费休法 | 0.84 |
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102560736A CN101759574B (zh) | 2009-12-25 | 2009-12-25 | 3-甲胺基-1,2-丙二醇的合成方法 |
US13/142,716 US8519191B2 (en) | 2009-12-25 | 2010-03-12 | Synthesis method of 3-methylamino-1, 2-propanediol |
PCT/CN2010/071007 WO2011075966A1 (zh) | 2009-12-25 | 2010-03-12 | 3-甲胺基-1,2-丙二醇的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102560736A CN101759574B (zh) | 2009-12-25 | 2009-12-25 | 3-甲胺基-1,2-丙二醇的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101759574A true CN101759574A (zh) | 2010-06-30 |
CN101759574B CN101759574B (zh) | 2012-08-15 |
Family
ID=42490976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102560736A Expired - Fee Related CN101759574B (zh) | 2009-12-25 | 2009-12-25 | 3-甲胺基-1,2-丙二醇的合成方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8519191B2 (zh) |
CN (1) | CN101759574B (zh) |
WO (1) | WO2011075966A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101962325A (zh) * | 2010-09-06 | 2011-02-02 | 张良臣 | 一种高纯度3-甲胺基-1,2-丙二醇的合成方法 |
WO2011075966A1 (zh) * | 2009-12-25 | 2011-06-30 | 潍坊中业化学有限公司 | 3-甲胺基-1,2-丙二醇的合成方法 |
NO20110238A1 (no) * | 2011-02-10 | 2012-08-13 | Borregaard As | Fremgangsmåte for fremstilling av aminoalkoholer |
CN103319354A (zh) * | 2013-05-14 | 2013-09-25 | 西安近代化学研究所 | 一种合成3-氨基-1,2-丙二醇的方法 |
CN105758970A (zh) * | 2016-05-17 | 2016-07-13 | 泰山医学院 | 一种气相色谱法检测3-甲胺基-1,2-丙二醇纯度的方法 |
CN106824005A (zh) * | 2017-02-12 | 2017-06-13 | 江苏诚信药业有限公司 | 制备盐酸乙胺丁醇的工艺系统 |
CN116836068A (zh) * | 2023-08-30 | 2023-10-03 | 内蒙古圣氏化学股份有限公司 | 一种连续化生产高纯度3-甲氨基-1,2-丙二醇的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1054837C (zh) * | 1995-11-20 | 2000-07-26 | 江苏省原子医学研究所 | 一种多元醇胺的制备方法 |
CN101759574B (zh) * | 2009-12-25 | 2012-08-15 | 郭学阳 | 3-甲胺基-1,2-丙二醇的合成方法 |
-
2009
- 2009-12-25 CN CN2009102560736A patent/CN101759574B/zh not_active Expired - Fee Related
-
2010
- 2010-03-12 US US13/142,716 patent/US8519191B2/en not_active Expired - Fee Related
- 2010-03-12 WO PCT/CN2010/071007 patent/WO2011075966A1/zh active Application Filing
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011075966A1 (zh) * | 2009-12-25 | 2011-06-30 | 潍坊中业化学有限公司 | 3-甲胺基-1,2-丙二醇的合成方法 |
CN101962325A (zh) * | 2010-09-06 | 2011-02-02 | 张良臣 | 一种高纯度3-甲胺基-1,2-丙二醇的合成方法 |
CN101962325B (zh) * | 2010-09-06 | 2013-12-11 | 五莲县千功精细化工有限公司 | 一种3-甲胺基-1,2-丙二醇的合成方法 |
NO20110238A1 (no) * | 2011-02-10 | 2012-08-13 | Borregaard As | Fremgangsmåte for fremstilling av aminoalkoholer |
NO332670B1 (no) * | 2011-02-10 | 2012-12-03 | Borregaard As | Fremgangsmåte for fremstilling av aminoalkoholer |
CN103319354A (zh) * | 2013-05-14 | 2013-09-25 | 西安近代化学研究所 | 一种合成3-氨基-1,2-丙二醇的方法 |
CN105758970A (zh) * | 2016-05-17 | 2016-07-13 | 泰山医学院 | 一种气相色谱法检测3-甲胺基-1,2-丙二醇纯度的方法 |
CN105758970B (zh) * | 2016-05-17 | 2018-05-15 | 泰山医学院 | 一种气相色谱法检测3-甲胺基-1,2-丙二醇纯度的方法 |
CN106824005A (zh) * | 2017-02-12 | 2017-06-13 | 江苏诚信药业有限公司 | 制备盐酸乙胺丁醇的工艺系统 |
CN116836068A (zh) * | 2023-08-30 | 2023-10-03 | 内蒙古圣氏化学股份有限公司 | 一种连续化生产高纯度3-甲氨基-1,2-丙二醇的方法 |
CN116836068B (zh) * | 2023-08-30 | 2023-11-03 | 内蒙古圣氏化学股份有限公司 | 一种连续化生产3-甲氨基-1,2-丙二醇的方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2011075966A1 (zh) | 2011-06-30 |
CN101759574B (zh) | 2012-08-15 |
US8519191B2 (en) | 2013-08-27 |
US20120277471A1 (en) | 2012-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101759574B (zh) | 3-甲胺基-1,2-丙二醇的合成方法 | |
CN102417162B (zh) | 一种盐酸-醋酸废液的回收利用方法 | |
CN102675102A (zh) | 一种连续生产高含量和高光学纯度乳酸酯的方法 | |
CN104628563A (zh) | 一种乳酸制备乳酸酯的合成工艺 | |
CN105272865A (zh) | 一种氯乙酸水相氨化法制备甘氨酸的新工艺 | |
CN111747828A (zh) | 一种乙二醇单丙基醚的制备方法及系统 | |
CN104190104B (zh) | 一种甘氨酸法生产草甘膦副产物的甲缩醛精制工艺设备及方法 | |
CN101648881B (zh) | 一种氨基甘油合成工艺 | |
CN106631835B (zh) | 一种3-甲胺基-1,2-丙二醇的生产方法 | |
CN112047851B (zh) | 一种d-泛醇的制备方法 | |
CN103509048B (zh) | 一种绿色氨磷汀的制备方法 | |
CN104829466A (zh) | 一种管道反应器合成3-甲胺基-1,2-丙二醇的方法 | |
CN110563669A (zh) | 一种提高吗啉纯度的方法及装置 | |
CN114409509A (zh) | 月桂醇纯化方法、聚多卡醇合成方法及聚多卡醇注射液 | |
CN104710285A (zh) | 一种乙二醇单甲醚的回收方法 | |
CN106431895B (zh) | 分子蒸馏结合萃取用于提取发酵液中乳酸的方法 | |
CN102850374A (zh) | 一种制备南大戟内酯b的方法 | |
CN103333110B (zh) | 一种药用月桂氮卓酮的生产方法 | |
CN100509757C (zh) | 15n-l-精氨酸的分离提纯方法 | |
CN110818548A (zh) | 一种制备苄叉丙酮的方法 | |
CN101962325A (zh) | 一种高纯度3-甲胺基-1,2-丙二醇的合成方法 | |
CN114957042B (zh) | 一种2,2,2-三氟乙脒的合成工艺 | |
CN108456138A (zh) | 一种醋酸乙酯的生产工艺 | |
CN103772224B (zh) | D-苏氨酸的制备方法 | |
CN114933546B (zh) | 一种适用于碘海醇大生产的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUO XUEYANG Free format text: FORMER OWNER: ZHANG ZHONGFA Effective date: 20120618 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Guo Xueyang Inventor after: Sun Chunxiu Inventor after: Wang Chunhui Inventor after: Li Qinghua Inventor after: Guo Yankai Inventor after: Guo Xiangrong Inventor after: Xu Dapeng Inventor after: Wang Liang Inventor after: Zhang Yunling Inventor after: Wang Xiaoli Inventor after: Sun Jiangyan Inventor before: Zhang Zhongfa |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG ZHONGFA TO: GUO XUEYANG LI QINGHUA GUO YANKAI GUO XIANGRONG XU DAPENG WANG LIANG ZHANG YUNLING WANG XIAOLI SUN JIANGYAN SUN CHUNXIU WANG CHUNHUI |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120618 Address after: 262737 Lingang Industrial Park, Binhai Economic Development Zone, Weifang, Shandong Applicant after: Guo Xueyang Address before: Binhai Economic Development Zone, Shandong city of Weifang province Dajiawa 262737 streets in Weifang Haihua Street South Lion Chemical Limited by Share Ltd Applicant before: Zhang Zhongfa |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO ZHONGKE RONGDA NEW MATERIAL CO., LTD. Free format text: FORMER OWNER: GUO XUEYANG Effective date: 20150417 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 262737 WEIFANG, SHANDONG PROVINCE TO: 266600 QINGDAO, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150417 Address after: 266600 No. 8-1 Longkou Road, Laixi Economic Development Zone, Shandong, Qingdao Patentee after: Qingdao Zhongke Rongda New Material Co., Ltd. Address before: 262737 Lingang Industrial Park, Binhai Economic Development Zone, Weifang, Shandong Patentee before: Guo Xueyang |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120815 Termination date: 20151225 |
|
EXPY | Termination of patent right or utility model |